Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q2 2022 vs. Q1 2022
How the institutions holding Sunshine Biopharma Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 13 | 18 | +5 |
| Shares | 1.47M | 737.5K | −732.2K (−49.8%) |
| Value | $3.55M | $802.1K | −$2.75M (−77.4%) |
New holders (9)
Institutions that held Sunshine Biopharma Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 568,400 | $614.0K | 0.01% |
| Bank of Montreal | 31,000 | $40.0K | 0.00% |
| Dakota Wealth Management | 20,000 | $22.0K | 0.00% |
| Advisor Group Holdings, Inc. | 7,528 | $8.00K | 0.00% |
| Morgan Stanley | 6,867 | $7.00K | 0.00% |
| Bank of America Corp | 3,330 | $4.00K | 0.00% |
| Citigroup Inc | 130 | $0 | 0.00% |
| Larson Financial Group LLC | 127 | $0 | 0.00% |
| Rise Advisors, LLC | 293 | $0 | 0.00% |
Sold out (4)
Institutions that held Sunshine Biopharma Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Armistice Capital, LLC | 635,002 | $1.56M |
| Empery Asset Management, LP | 450,450 | $1.10M |
| Hudson Bay Capital Management LP | 315,000 | $720.0K |
| Jane Street Group, LLC | 12,640 | $31.0K |